Yarrow Bioscience Inc (YARW) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Yarrow Bioscience Inc (YARW) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

YARW Cash Flow Statement

Yarrow Bioscience Inc (YARW) cash flow statement — 11-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-1.99M	-4.08M	-3.76M	-7.1M	-10.8M	-11.46M	-9M	-8.51M	-8.48M	-7.98M	-5.14M	-5.15M	-9.57M	-5.48M	-3.88M	-7.13M	-8.22M	-9.04M	-10.02M	-17.54M
Operating CF Margin %	-2053.61%	-4745.35%	-2895.38%	-4198.82%	-15656.52%	-5673.76%	-10713.1%	-7033.06%	-4283.84%	-8143.88%	-6759.21%	-4519.3%	-7091.85%	-5533.33%	-64583.33%	-4266.47%	-6527.78%	-5078.09%	-437.09%	-13188.72%
Operating CF Growth %	81.56%	64.39%	58.17%	16.62%	-27.36%	-43.6%	-	-	-	-	-32.57%	27.69%	-16.4%	39.4%	61.32%	59.38%	49.41%	27.98%	60.52%	25.79%
Net Income	-2.9M	-3.58M	-4.84M	-7.28M	-5.75M	-8.61M	-12.01M	-12.16M	-9.41M	-6.25M	-6.19M	-6.07M	-10.04M	-5.61M	-9.95M	-9.26M	-8.48M	4.67M	-11.57M	-14.28M
Depreciation & Amortization	6K	6K	5K	6K	6K	6K	4K	0	0	0	0	0	0	0	-155K	171K	12K	44K	26K	28K
Stock-Based Compensation	0	474K	529K	487K	529K	763K	0	734K	885K	985K	710K	0	0	0	1.07M	0	1.16M	893K	1.33M	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	93K	0
Other Non-Cash Items	-57K	-18K	-90K	-150K	-214K	-324K	146K	-505K	-616K	-778K	-254K	350K	856K	846K	280K	1.01M	40K	-12.99M	1.3M	-1.74M
Working Capital Changes	958K	-958K	629K	-159K	-5.37M	-3.29M	2.87M	3.42M	655K	-1.94M	595K	569K	-392K	-712K	4.88M	950K	-964K	-1.65M	-1.2M	-1.55M
Change in Receivables	-202K	202K	2.27M	1.63M	1.07M	-768K	688K	2.54M	-2.83M	-1.29M	482K	-16K	-129K	68K	2.36M	877K	231K	7.98M	2.45M	996K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	97K	779K	209K
Change in Payables	1.16M	-1.16M	-1.65M	-1.77M	-6.41M	-2.49M	2.2M	903K	3.52M	-611K	993K	77K	0	0	0	104K	0	0	-2.67M	-3.09M
Cash from Investing	300K	4.7M	8.46M	4.4M	4.67M	19.83M	12.74M	-4.82M	19.02M	-3.57M	-62.35M	0	0	5M	-935K	-86K	0	15.75M	0	0
Capital Expenditures	0	0	0	0	0	0	-117K	0	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	139.29%	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	5M	-935K	-86K	0	15.75M	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	-62.35M	0	0	0	0	0	0	0	0	0
Cash from Financing	-14K	-15K	-15K	-7K	-34K	-87K	-132K	-2K	-2K	-5K	82.66M	-47K	-5K	-217K	208K	-26K	-61K	1.53M	-38K	-33.56M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-36.43M
Equity Issued (Net)	0	-15K	-15K	-7K	-34K	-87K	0	0	0	0	82.67M	-47K	-5K	-217K	-1K	-26K	-86K	1.56M	-29K	2.87M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	-15K	-7K	-34K	0	0	0	0	0	0	0	0	-360K	0	0	0	0	0	0
Other Financing	-14K	0	0	0	0	0	-132K	-2K	-2K	-5K	-2K	0	0	0	209K	0	25K	-25K	-9K	0
Net Change in Cash	-1.71M	604K	4.68M	-2.7M	-6.16M	8.28M	3.61M	-13.34M	10.54M	-11.55M	15.17M	-5.2M	-9.58M	-695K	-4.6M	-7.24M	-8.29M	8.24M	-10.06M	-51.1M
Free Cash Flow	-1.99M	-4.08M	-3.76M	-7.1M	-10.8M	-11.46M	-9.12M	-8.51M	-8.48M	-7.98M	-5.14M	-5.15M	-9.57M	-5.48M	-3.88M	-7.13M	-8.22M	-9.04M	-10.02M	-17.54M
FCF Margin %	-2053.61%	-4745.35%	-2895.38%	-4198.82%	-15656.52%	-5673.76%	-10852.38%	-7033.06%	-4283.84%	-8143.88%	-6759.21%	-4519.3%	-7091.85%	-5533.33%	-64583.33%	-4266.47%	-6527.78%	-5078.09%	-437.09%	-13188.72%
FCF Growth %	81.56%	64.39%	58.71%	16.62%	-27.36%	-43.6%	-	-	-	-	-32.57%	27.69%	-16.4%	39.4%	61.32%	59.38%	49.41%	27.98%	60.7%	25.79%
FCF per Share	-2.32	-4.77	-5.65	-8.29	-12.63	-13.43	-10.70	-9.99	-9.96	-9.37	-8.27	-1.57	-2.93	-1.68	-1.30	-2.21	-2.56	-2.94	-3.37	-6.07
FCF Conversion (FCF/Net Income)	0.66x	1.14x	0.78x	0.97x	1.88x	1.33x	0.75x	0.70x	0.90x	1.28x	0.83x	0.78x	0.95x	0.97x	0.39x	0.75x	0.97x	-1.94x	0.87x	0.82x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0